Director, Research ProgramsAmerican Thrombosis and Hemostasis NetworkRochester, New York, United States
PB0229 - DESIGNING THE RYPLAZIM® (PLASMINOGEN, HUMAN-tvmh) ARM OF ATHN TRANSENDS: SAFETY AND EFFECTIVENESS IN PEOPLE WITH PLASMINOGEN DEFICIENCY
Sunday, June 25, 202318:30 – 19:30 ET
PB0625 - Emicizumab Prophylaxis in People with Hemophilia A Aged ≥50 Years with Comorbidities: Experience From the ATHN 7 Hemophilia Natural History Study
Monday, June 26, 202318:30 – 19:30 ET
PB0629 - Designing the Efanesoctocog Alfa Module of ATHN Transcends: Safety, Tolerability, and Effectiveness in Previously Untreated Patients with Hemophilia A
